NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analyst
Proactive research analyst John Savin speaks to Thomas Warner after releasing a new report on NanoViricides (NYSE-A:NNVC), a development-stage company that...
Stay updated with breaking news from John Savin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Proactive research analyst John Savin speaks to Thomas Warner after releasing a new report on NanoViricides (NYSE-A:NNVC), a development-stage company that...
Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a...
Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a...
Proactive research analyst John Savin speaks to Thomas Warner at the London studio after releasing his latest report into commercial-stage specialty...
Proactive research analyst John Savin speaks to Thomas Warner after publishing a new report on Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP,...